ONCE - Spark Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Spark Therapeutics's activity chart (see below) currently has 127 price targets and 96 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 95.78% with an average time for these price targets to be met of 182.09 days.

Most recent stock forecast was given by PHIL NADEAU from TD COWEN on 25-Mar-2019. First documented stock forecast 24-Feb-2015.

Best performing analysts who are covering ONCE - Spark Therapeutics:

Elemer Piros Reni Benjamin Edward Nash Phil Nadeau Mohit Bansal

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Feb-2015

$80

7 years 7 months 7 days ago
(25-Mar-2019)

7/7 (100%)

$23.99 (42.83%)

386

Buy Since 25-Mar-2019

$115

$1.43 (1.26%)

7 years 7 months 7 days ago
(25-Mar-2019)

7/8 (87.5%)

$1.47 (1.29%)

248

Buy Since 02-Aug-2017

$65

$-48.57 (-42.77%)

$65

7 years 8 months 5 days ago
(27-Feb-2019)

8/9 (88.89%)

$-48.4 (-42.68%)

179

$114.5

$0.93 (0.82%)

$48

7 years 8 months 6 days ago
(26-Feb-2019)

12/13 (92.31%)

$1.05 (0.93%)

122

Buy Since 12-Jul-2016

$72

7 years 8 months 6 days ago
(26-Feb-2019)

6/6 (100%)

$16.24 (29.12%)

280

Show more analysts

Please expand the browser size to see the chart

What is ONCE (Spark Therapeutics) average time for price targets to be met?

On average it took 182 days for the stock forecasts to be reached, with an average price target met ratio of 95.78%.

Which analyst most recently updated their price target on ONCE (Spark Therapeutics)?

Phil Nadeau

Which analyst has the most public recommendations on ONCE (Spark Therapeutics)?

Phil Nadeau works at TD COWEN and has 36 price targets and 25 ratings on ONCE

Which analyst is the currently most bullish on ONCE (Spark Therapeutics)?

Gena Wang with the highest potential upside of $1.43

Which analyst is the currently most reserved on ONCE (Spark Therapeutics)?

David Nierengarten with the lowest potential downside of -$73.57
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?